MCI (mild cognitive impairment)

Citations 11-20 of 131 total displayed.

Past content (since Jan 2001):

ARTICLES
Predicting the time of conversion to MCI in the elderly. Role of verbal expression and learning

Abderrahim Oulhaj, Gordon K. Wilcock, A. David Smith, and Celeste A. de Jager
Neurology first published on September 30, 2009 as doi: WNL.0b013e3181c0665f. [Abstract] Rapid PDF  

ARTICLES
Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study

K. L. Triebel, R. Martin, H. R. Griffith, J. Marceaux, O. C. Okonkwo, L. Harrell, D. Clark, J. Brockington, A. Bartolucci, and D. C. Marson
Neurology 2009; 73: 928-934. [Abstract] [Full text] [PDF]  

ARTICLES
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

W.J.P. Henneman, H. Vrenken, J. Barnes, I. C. Sluimer, N. A. Verwey, M. A. Blankenstein, M. Klein, N. C. Fox, P. Scheltens, F. Barkhof, and W. M. van der Flier
Neurology 2009; 73: 935-940. [Abstract] [Full text] [PDF]  

ARTICLES
Conversion of amyloid positive and negative MCI to AD over 3 years: An ¹¹C-PIB PET study

A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer, K. Någren, R. Bullock, Z. Walker, A. Kennedy, N. C. Fox, M. N. Rossor, J. O. Rinne, and D. J. Brooks
Neurology 2009; 73: 754-760. [Abstract] [Full text] [PDF]  

ARTICLES
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease

Alberto Pilotto, M. Franceschi, G. D’Onofrio, A. Bizzarro, F. Mangialasche, L. Cascavilla, F. Paris, M. G. Matera, Andrea Pilotto, A. Daniele, P. Mecocci, C. Masullo, B. Dallapiccola, and D. Seripa
Neurology 2009; 73: 761-767. [Abstract] [Full text] [PDF]  

ARTICLES
Subclinical cerebrovascular disease in mild cognitive impairment

J. A. Luchsinger, A. M. Brickman, C. Reitz, S. J. Cho, N. Schupf, J. J. Manly, M. X. Tang, S. A. Small, R. Mayeux, C. DeCarli, and T. R. Brown
Neurology 2009; 73: 450-456. [Abstract] [Full text] [PDF]  

ARTICLES
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease

C. R. McDonald, L. K. McEvoy, L. Gharapetian, C. Fennema-Notestine, D. J. Hagler, Jr, D. Holland, A. Koyama, J. B. Brewer, A. M. Dale For the Alzheimer’s Disease Neuroimaging Initiative
Neurology 2009; 73: 457-465. [Abstract] [Full text] [PDF]  

ARTICLES
Conversion of amyloid positive and negative MCI to AD over 3 years. An ¹¹C-PIB PET study

A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer, K. Någren, R. Bullock, Z. Walker, A. Kennedy, N. C. Fox, M. N. Rossor, J. O. Rinne, and D. J. Brooks
Neurology first published on July 22, 2009 as doi: WNL.0b013e3181b23564. [Abstract] Rapid PDF  

ARTICLES
Conversion of amyloid positive and negative MCI to AD over 3 years. An ¹¹C-PIB PET study

A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer, K. Någren, R. Bullock, Z. Walker, A. Kennedy, N. C. Fox, M. N. Rossor, J. O. Rinne, and D. J. Brooks
Neurology first published on July 8, 2009 as doi: WNL.0b013e3181b23564. [Abstract] Rapid PDF  

ARTICLES
Donepezil delays progression to AD in MCI subjects with depressive symptoms

P. H. Lu, S. D. Edland, E. Teng, K. Tingus, R. C. Petersen, J. L. Cummings On behalf of The Alzheimer's Disease Cooperative Study Group
Neurology 2009; 72: 2115-2121. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14